Skip to main content
Premium Trial:

Request an Annual Quote

Ardy Arianpour

Ardy Arianpour has joined BaseHealth as the company's chief business officer.

Arianpour has over 14 years of experience in the genomics market. Prior to joining BaseHealth, he was chief commercial officer at Pathway Genomics. Before that, he held senior executive roles at Ambry Genetics and Cogenics. He also sits on advisory boards for Vitagene and Celmatix and is founder and managing partner for Octyne. 

Arianpour has a BS in biology from the University of California, Irvine, and an MBA in strategic management from Marshall Goldsmith School of Management.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.